Radiotherapy after radical prostatectomy in patients with prostate-specific antigen elevation

被引：0
|
作者：
Wiegel, T [1 ]
Hinkelbein, W [1 ]
机构：
[1] Free Univ Berlin, Hosp Benjamin Franklin, Dept Radiotherapy, D-1000 Berlin, Germany
来源：
CONTROVERSIES IN URO-ONCOLOGY | 2002年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 42
页数：8
相关论文
共 50 条
  • [41] Re: Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer
    Walsh, PC
    [J]. JOURNAL OF UROLOGY, 2000, 164 (04): : 1322 - 1323
  • [42] THE EFFICACY OF POSTPROSTATECTOMY RADIOTHERAPY IN PATIENTS WITH AN ISOLATED ELEVATION OF SERUM PROSTATE-SPECIFIC ANTIGEN
    WU, JJ
    KING, SC
    MONTANA, GS
    MCKINSTRY, CA
    ANSCHER, MS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 317 - 323
  • [43] Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy
    Mouraviev, Vladimir
    Sun, Leon
    Madden, John F.
    Mayes, Janice M.
    Moul, Judd W.
    Polascik, Thomas J.
    [J]. UROLOGY, 2007, 70 (06) : 1141 - 1145
  • [44] Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer
    Naito, S
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (07) : 365 - 374
  • [45] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era Editorial Comment
    Walsh, Patrick C.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02): : 553 - 554
  • [46] Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression
    Lohm, Gunnar
    Neumann, Konrad
    Budach, Volker
    Wiegel, Thomas
    Hoecht, Stefan
    Gollrad, Johannes
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (04) : 325 - 332
  • [47] Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy
    Martini, Alberto
    Fossati, Nicola
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    Boeri, Luca
    Bossi, Alberto
    Di Muzio, Nadia
    Cozzarini, Cesare
    Chiorda, Barbara Noris
    Gandaglia, Giorgio
    Robesti, Daniele
    Bartkowiak, Detlef
    Boehmer, Dirk
    Shariat, Shahrokh F.
    Goldner, Gregor
    Battaglia, Antonino
    Joniau, Steven
    Berghen, Charlien
    De Meerleer, Gert
    Fonteyne, Valerie
    Ost, Piet
    Van Poppel, Hein
    Montorsi, Francesco
    Wiegel, Thomas
    Briganti, Alberto
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 301 - 304
  • [48] Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
    Umezawa, Rei
    Ariga, Hisanori
    Ogawa, Yoshihiro
    Jingu, Keiichi
    Matsushita, Haruo
    Takeda, Ken
    Fujimoto, Keisuke
    Sakayauchi, Toru
    Sugawara, Toshiyuki
    Kubozono, Masaki
    Narazaki, Kakutaro
    Shimizu, Eiji
    Takai, Yoshihiro
    Yamada, Shogo
    [J]. RADIATION ONCOLOGY, 2011, 6
  • [49] Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy
    Pearse, Maria
    Choo, Richard
    Danjoux, Cyril
    Gardner, Sandra
    Morton, Gerard
    Szumacher, Ewa
    Lorlaw, Andrew
    Cheung, Patrick
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 792 - 798
  • [50] DISTANT METASTASIS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITHOUT AN ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL
    LEIBMAN, BD
    DILLIOGLUGIL, O
    WHEELER, TM
    SCARDINO, PT
    [J]. CANCER, 1995, 76 (12) : 2530 - 2534
12345